Search
Neumora Therapeutics Inc
NMRAAdd to Watchlist
1.610USD
-0.040-2.42%
Close 07-31 16:00（ET）Quotes delayed by 15 min
298.31MMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Amgen Inc
19.09%
ARCH Venture Partners
18.27%
Invus Public Equities Advisors, LLC
4.59%
Berns (Paul L)
4.16%
SB Global Advisers Ltd
3.47%
Other
50.43%
Shareholders
Shareholders
Proportion
Amgen Inc
19.09%
ARCH Venture Partners
18.27%
Invus Public Equities Advisors, LLC
4.59%
Berns (Paul L)
4.16%
SB Global Advisers Ltd
3.47%
Other
50.43%
Shareholder Types
Shareholders
Proportion
Investment Advisor
21.86%
Venture Capital
19.33%
Corporation
19.09%
Hedge Fund
7.86%
Individual Investor
4.52%
Investment Advisor/Hedge Fund
2.61%
Endowment Fund
1.79%
Research Firm
1.37%
Pension Fund
0.12%
Other
21.45%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
301
106.55M
57.52%
-16.54M
2025Q4
291
86.53M
52.51%
-28.54M
2025Q3
293
86.79M
53.64%
-40.47M
2025Q2
288
142.02M
87.70%
-25.57M
2025Q1
283
144.00M
90.43%
+12.16M
2024Q4
249
161.18M
99.54%
+45.20M
2024Q3
201
148.65M
93.66%
+40.67M
2024Q2
179
142.61M
90.03%
+47.65M
2024Q1
154
133.89M
85.01%
+50.39M
2023Q4
108
122.49M
78.90%
+50.97M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Amgen Inc
35.37M
19.43%
--
--
Apr 10, 2025
ARCH Venture Partners
33.85M
18.59%
+1.92M
+6.00%
Oct 27, 2025
Invus Public Equities Advisors, LLC
9.00M
4.94%
+2.71M
+43.08%
Feb 13, 2026
Berns (Paul L)
7.67M
4.21%
-9.82K
-0.13%
Feb 17, 2026
SB Global Advisers Ltd
6.43M
3.53%
-111.47K
-1.70%
Dec 31, 2025
MIC Capital Management UK LLP
4.46M
2.45%
--
--
Dec 31, 2025
Point72 Asset Management, L.P.
3.67M
2.02%
+3.67M
--
Dec 31, 2025
Millennium Management LLC
3.62M
1.99%
+1.61M
+80.08%
Dec 31, 2025
Fidelity Management & Research Company LLC
3.50M
1.92%
-3.46K
-0.10%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Invesco Nasdaq Biotechnology ETF
0.05%
ProShares Ultra Nasdaq Biotechnology
0.04%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
iShares Biotechnology ETF
0.02%
Schwab U.S. Small-Cap ETF
0.01%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
0%
iShares US Small-Cap Equity Factor ETF
0%
Virtus LifeSci Biotech Clinical Trials ETF
0%
Fidelity MSCI Health Care Index ETF
0%
Schwab U.S. Broad Market ETF
0%
View more
Invesco Nasdaq Biotechnology ETF
Proportion0.05%
ProShares Ultra Nasdaq Biotechnology
Proportion0.04%
Invesco RAFI US 1500 Small-Mid ETF
Proportion0.02%
iShares Biotechnology ETF
Proportion0.02%
Schwab U.S. Small-Cap ETF
Proportion0.01%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proportion0%
iShares US Small-Cap Equity Factor ETF
Proportion0%
Virtus LifeSci Biotech Clinical Trials ETF
Proportion0%
Fidelity MSCI Health Care Index ETF
Proportion0%
Schwab U.S. Broad Market ETF
Proportion0%